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R. Maronpot1, George Lucier1, and Christopher J. Portier1
Cancer, by definition, is a proliferative disease. The fundamental scientific issue explored at
the international symposium "Cell Proliferation and Chemical Carcinogenesis" was the impact
of chemically enhanced cell proliferation on the dynamic carcinogenic processes. This confer-
ence, held at the National Institute ofEnvironmental Health Sciences January 14-16, 1992, pro-
vided an open forum for the exchange of new results, information, and ideas in four areas: a)
general principles ofcell division and carcinogenesis, b) critical evaluation of cell proliferation
methodologies, c) cell proliferation and modeling of organ-specific carcinogenesis, and d) cell
proliferation and human carcinogenesis. This overview summarizes key findings from that sym-
posium. The general view expressed was that although cell proliferation is involved inextrica-
bly in the development of cancers, chemically enhanced cell division does not reliably predict
carcinogenicity. Our knowledge of the multistep nature of carcinogenesis has advanced sub-
stantially during recent years; however, much still needs to be learned. A greater understand-
ing ofthe cellular and molecular events in chemical carcinogenesis should improve all aspects
of the overall risk assessment process, including extrapolations based on dose, species, and
interindividual differences.
Introduction
Cell proliferation has long been recognized as an
important factor in human and experimental carcino-
genesis. The fixation of carcinogen-induced promuta-
genic DNA damage into heritable mutations and the
clonal expansion of initiated cells are two of the steps
in the carcinogenesis process that are likely enhanced
by cell proliferative stimuli. Partly because cell prolif-
eration is an integral component of the carcinogenic
process, controversy has emerged over how and to
what extent chemically induced cell proliferation influ-
ences the carcinogenic process. In one view, an
increased rate ofcell division may lead to carcinogene-
sis; in the other, cell proliferation is considered to be
one of many factors involved. An extension of this
debate is the opinion that if cell proliferation per se is a
primary mechanism of carcinogenesis for some chemi-
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cals that do not appear to react with DNA, there
would be no increased cancer risk for those chemicals
at exposures that do not cause a sustained prolifera-
tive response.
An earlier conference, "Chemically Induced Cell
Proliferation: Implications for Risk" (1), held in 1989,
drew attention and scientific interest to the possible
importance of cell proliferation data in the evaluation
of animal carcinogenicity studies. Since that time, new
data have been generated, and hypotheses related to
the role of cell proliferation in chemical carcinogenesis
have been refined.
The present symposium was organized to provide a
forum for an open exchange of results and ideas relat-
ed to how chemically induced cell proliferation affects
the carcinogenic process and on whether cell prolifera-
tion data would be useful in cancer risk assessments.
The results ofscientific debates on this topic are partic-
ularly important because they may be used to formu-
late national and international public health policies.
Participants in this conference comprised a wide
range of scientific backgrounds and interests and
included cellular and molecular biologists and bio-
chemists active in the area of cell cycle control and
gene expression, toxicologists and experimental
pathologists studying chemically induced cell prolifera-
tion, statisticians attempting to model chemical car-MELNICK ET AL.
cinogenesis, and representatives of regulatory and
research agencies responsible for estimating human
cancer risk. The conference was held at the National
Institute of Environmental Health Sciences (NIEHS)
in Research Triangle Park, North Carolina, January
14-16, 1992, and was sponsored by the NIEHS, the
Chemical Industry Institute of Toxicology (CIIT), the
International Life Sciences Institute-Risk Science
Institute (ILSI-RSI), and the American Industrial
Health Council (AIHC). Approximately 500 people
attended, with participants from Austria, Canada,
France, Germany, Great Britain, Italy, Japan, Swe-
den, and the United States. This symposium overview
was authored by members of the scientific program
committee.
The conference was organized to address three
major questions related to cell proliferation and chemi-
cal carcinogenesis: a) Can the stimulation of cell divi-
sion alone lead to a carcinogenic response? b) What is
the mechanistic role ofcell proliferation in the carcino-
genic process? If chemically induced cell proliferation
is detected in an organ that had an increased incidence
of tumors, we need to determine whether enhanced
cell replication was involved in the process or was pri-
marily responsible for the cancer. c) Should cell prolif-
eration data be used in cancer risk assessment; if so,
how?
To address these questions, the conference was organ-
ized into four platform sessions consisting of 27 sepa-
rate presentations, two conference summations with
discussions of future directions, plus 38 poster presen-
tations. The sessions were a) general principles of cell
division and carcinogenesis, chaired by H. Yamasaki
(International Agency for Research on Cancer) and J.
C. Barrett (NIEHS), b) critical evaluation ofcell prolif-
eration methodologies, chaired by R. Maronpot
(NIEHS), c) cell proliferation and modeling of organ-
specific carcinogenesis, chaired by J. Popp (CIIT) and
G. Lucier (NIEHS), d) cell proliferation and human
carcinogenesis, chaired by A. Upton (New York Uni-
versity), e) summation and future directions, presented
by J. Swenberg (University of North Carolina) and I.
B. Weinstein (Columbia University).
A brief summary and overview of the data and key
findings presented at the symposium are given here.
More details and extended discussions can be obtained
from the individual papers that comprise these pro-
ceedings.
General Principles of Cell Division
and Carcinogenesis
To help understand relationships between cell prolif-
eration and chemical carcinogenesis, it is important to
recognize and understand the complex cellular
processes involved in cell cycle control (2) and the rela-
tionships between DNA damage, DNA repair, and
cell-cycle progression (3). It has been postulated that
perturbations of cell-cycle controls may cause genetic
instability that can increase spontaneous DNA damage
and lead to tumor initiation. However, multiple check
points exist during the growth arrest phases ofthe cell
cycle that presumably permit repair of DNA damage
before cell division. DNA damage at cell-cycle check
points (e.g., mutations of the p53 gene may be critical
in carcinogenesis by establishing cellular lineages
capable of undergoing replicative DNA synthesis with
a damaged template (4).
Other factors important in understanding the pro-
cess of chemical carcinogenesis include a) identifying
the cell from which a particular cancer originates [e.g.,
maturation-arrested stem cell or dedifferentiated
mature cell (5)]; b) clarifying the role and relationship
of gap junctional intercellular communication and cell
proliferation in tumor promotion and progression (6);
and c) determining factors involved in regulation of
programmed cell death (7). An increase in the life span
ofa genetically altered cell could increase the possibili-
ty of that cell undergoing malignant transformation.
In the skin, chemically induced sustained hyperplasia
correlates well with tumor-promoting activity; howev-
er, there is no evidence that cell proliferation, without
initiation by a DNA-altering agent, produces skin
tumors (8).
The suggestion has been made that increased cell
proliferation increases the probability of mutations
arising from endogenous oxidative DNA damage, and
thus agents given at doses that increase cell prolifera-
tion will likely be carcinogenic (9). In contrast to this
view, an examination of site-specific histopathologic
correspondence between carcinogenicity and chemical-
ly induced target organ toxicity for approximately 500
long-term experiments in rats and mice did not demon-
strate a correlation between these two morphologic
end points (10). Thus cytotoxicity does not necessarily
predispose a tissue to cancer; organ toxicity occurs
without evidence of carcinogenesis and carcinogenesis
occurs without evidence of toxicity. Furthermore, in
some experimental models, mitogen-induced liver
growth, unlike compensatory cell proliferation, was
ineffective in supporting the initiation or promotion of
liver carcinogenesis (11). It is also hypothesized that
increased cell proliferation may result in DNA hypo-
methylation, leading to increased expression of proto-
oncogenes involved in carcinogenesis (12).
Critical Evaluation of Cell
Proliferation Methodologies
Chemically induced cell proliferation is generally
assessed after the administration of DNA precursor
labels, 3H-thymidine or bromodeoxyuridine, or by
analysis of endogenous cell replication markers, such
as proliferating cell nuclear antigen (13). Measure-
ments ofoverall cell replication in an organ do not dis-
tinguish between cell division in normal differentiated
cells from that in stem cells or in preneoplastic cells.
To better understand potential relationships between
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cell proliferation and chemical carcinogenesis, a consid-
erably larger database is needed ofsustained cell repli-
cation induced by mitogenic and cytotoxic chemicals in
target cell populations and in preneoplastic lesions.
Subtle treatment-related differences in labeling index
can be detected with properly designed experiments,
by analyzing a sufficient number of tissue samples to
minimize variance in estimated values, and by employ-
ing appropriate statistical evaluations (14). In addition,
quantification of cell proliferation in the rodent liver
using DNA precursor labels or by measuring mitotic
activity should be considered in conjunction with the
variables of hepatocyte ploidy and nuclearity in rats
and mice (15); this can be partly facilitated by using
flow cytometry in conjunction with DNA labeling tech-
niques.
Cell Proliferation and Modeling
Organ-Specific Carcinogenesis
Studies of proliferative responses in specific organ
systems and mathematical models of chemical carcino-
genesis were presented to further explore relation-
ships between these processes. Although an empirical
association between cell proliferation and cancer in
certain tissues of rodents and humans has been pro-
posed, an increasing number of examples have been
found in which cell proliferation or chronic toxicity and
epithelial cell degeneration/regeneration was not asso-
ciated with carcinogenesis (16). Chemically induced
cell proliferation frequently does not correlate, qualita-
tively orquantitatively, with the developmentoftumors.
The data currently used for estimating parameters in
mathematical models of carcinogenesis are generally
not sufficient to differentiate between chemical effects
on initiation, promotion, progression, or completion
stages (17). These data also fail to allow multistage
models of carcinogenesis that incorporate growth
kinetic data to be distinguished from those that do not
(e.g., Armitage-Doll models). Furthermore, measuring
mitotic rates without considering relative changes in
DNA repair may not necessarily provide meaningful
estimates of changes in mutation rates. Mathematical
models that reduce complex processes to single para-
meters may lead to erroneous results.
The growth of normal tissue and of cancer tissue is
determined by the difference between rates of cell
replication and cell death. Studies on the regulation of
apoptosis (programmed cell death) may be helpful for
understanding mechanisms of initiation and promotion
of liver cancer (18) and of tumor development in other
organs. Transforming growth factor, TGF-f1, appears
to be involved in the initiation of apoptosis in hepato-
cytes. Experimental studies of liver carcinogenesis
indicate that initiated cells may die without giving rise
to intermediate populations of preneoplastic foci; this
occurrence has also been predicted in mathematical
models ofcarcinogenesis that include rates of cell divi-
sion and rates ofcell death as separate parameters (19).
In experimental studies of skin carcinogenesis, stim-
ulation of epidermal cell proliferation alone is not a
reliable predictor of tumor promotion; hyperplastic
transformation with keratinocyte activation and the
release of growth factors are critical for tumor devel-
opment (20). A stochastic-based mathematical model of
skin tumor promotion predicts that initiated cells may
not exhibit agrowth advantage overnormal cells (21).
Induced cell proliferation was proposed to influence
dose-response relationships for urinary bladder car-
cinogenesis induced by genotoxic chemicals and to be
an important factor in the induction ofurinary bladder
cancers by certain nongenotoxic chemicals [e.g., sodi-
um saccharin (22)]. Formation of microcrystals con-
taining sodium saccharin in alkaline urine of rodents
may be responsible for the enhanced urothelial prolif-
eration that is associated with the induction ofbladder
tumors by sodium saccharin. oc-Globulin nephropathy
and sustained increases in cell proliferation have been
correlated with kidney neoplasia in male rats exposed
to unleaded gasoline and to d-limonene; additional cor-
relative studies and a better understanding ofmechan-
isms of chemically induced renal cell proliferation are
necessary before cause-and-effect relationships can be
established (23). In studies of nasal lesions induced by
inhaled chemicals, correlations between site specificity
ofcarcinogenesis and increases in cell proliferation are
important in understanding relationships between
these two occurrences and in assessing human risk.
Although sustained increases in cell proliferation
appear to be relevant to nasal carcinogenesis induced
by formaldehyde, it was also noted that some inhaled
irritant gases do not induce nasal tumors after chronic
exposure (24). Various nonmutagenic phenolic antioxi-
dants (e.g., BHA: butylated hydroxyanisole, caffeic acid,
sesamol, 4-methoxyphenol) cause dysplastic lesions
with accompanying increases in DNA synthesis in the
forestomach of the rat; these lesions persist after ces-
sation of chemical treatment and presumably play a
role in the development of forestomach carcinomas
(25).
Cell Proliferation and Human
Carcinogenesis
Mutations in the p53 tumor-suppressor gene may
alter cell-cycle control, differentiation, and neoplastic
potential and are often present in diverse types of
human cancer. Inactivation ofp53 may occur by genet-
ic or epigenetic (e.g., DNA hypomethylation) alter-
ations (26). Human cancers associated with steroid
hormones, drugs, infectious agents, chemicals, or
chronic irritation were suggested to be due to an
increase in the rate of genetic errors resulting from
enhanced cell division (27).
Different views were expressed by representatives
of regulatory and international cancer research agen-
cies. For nonmutagenic compounds that produce toxic
lesions or regenerative hyperplasia before the forma-
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tion of tumors, it may be possible to establish a safe
level ofexposure by determining the threshold level of
response and applying a suitable safety factor (28).
Risk assessments should factor in cell proliferation
data for chemicals that are believed to cause cancer
secondary to enhanced cell replication (29). All factors
that are known to influence the carcinogenic response
should be incorporated into quantitative estimates of
human cancer risk; however, the use of cell prolifera-
tion data to modify tumor dose-response data has not
beenjustified (30). A greater understanding ofcarcino-
genic mechanisms is needed before data on chemically
induced cell proliferation can become incorporated into
an overall evaluation ofcarcinogenicity (31).
Summation and Future Directions
Although cell proliferation is involved in the devel-
opment of cancer, chemically enhanced cell division
does not reliably predict carcinogenicity. To clarify the
role of cell proliferation in chemical carcinogenesis, a
larger database is needed on possible dose-response
correlations between sustained cell proliferation and
carcinogenicity. Further work is also needed to
increase our understanding of factors influencing sex,
species, or tissue specificity and to enable comparisons
between the mutational spectra for background
tumors and those associated with chemically induced
cell proliferation in normal tissue (32). Many animal
organ systems can tolerate high levels ofcell prolifera-
tion without developing cancers. Molecular biomarkers
are needed that will identify and distinguish clinical
and subclinical changes occurring in normal cells
undergoing neoplastic transformation (33). A greater
understanding of the cellular and molecular events in
chemical carcinogenesis should improve all aspects of
the risk assessment process, including extrapolations
based on dose, species, and interindividual differences.
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